Upcoming Thematic Issue – Development of Nanoparticulate Formulations with Biomedical Applications related to Cancer – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Codruta Soica

http://benthamscience.com/journals/current-medicinal-chemistry/#top

Upcoming Thematic Issue – To find new Targets for the Inhibition of Epileptogenesis – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Ni Hong

http://benthamscience.com/journals/current-medicinal-chemistry/special-issues/

Upcoming Thematic Issue – To find new Targets for the inhibition of Epileptogenesis – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Ni Hong

http://benthamscience.com/journals/current-medicinal-chemistry/special-issues/

Upcoming Thematic Issue – Carbon-based nanostructure for Biomedical Application – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Dr. Hongmin Chen, Ph.D.

http://benthamscience.com/journals/current-medicinal-chemistry/special-issues/

 

Upcoming Thematic Issue – Visualizing the scope of Nano Drug Delivery as Topical Therapeutics – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Dr Vandita Kakkar

http://benthamscience.com/journals/current-medicinal-chemistry/#top

Upcoming Thematic Issue – Therapy based on the regulation of thiol-dependent Redox Systems – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Prof. Jun Lu, PhD

http://benthamscience.com/journals/current-medicinal-chemistry/#top

Highlighted Article – Glioblastoma Multiforme, Diagnosis and Treatment– Current Medicinal Chemistry

CMC-Articles_24-42-Noam Asna

http://www.eurekaselect.com/152454/article

Upcoming Thematic Issue – Managing side effects on ocular surface caused by glaucoma eve drops – Current Medicinal Chemistry

CMC-THEMATIC FLYER -Antonio Ferreras

http://benthamscience.com/journals/current-medicinal-chemistry/#top

Testimonial by Ignazio Grattagliano!

Print

Contributed Article: “Nutrition as a Health Determinant in Elderly Patients

SMi EVENT – 7th annual Orphan Drugs and Rare Diseases UK!

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.

200 X 200 copykiuj

Aimed at an audience of senior scientists and oncology specialists involved in targeting rare diseases therapies and drug research, Orphan Drugs UK 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of clinical trial process. The 7th annual conference will capture expert insight through dedicated focus new therapies for different rare diseases, the importance of orphan drug development and reimbursement and repurposing.

Join us this October for strategic direction from the Rare Disease community and leverage your knowledge with the key requirements and tools for successful patient recruitment and retention through informed guidance delivered by a panel of industry experts.

 

Exclusive highlights in 2017:

  • Learn about new therapies for different rare diseases, and how these can successfully be applied to other diseases with similar attributes
  • Hear what opportunities and challenges come with working on rare diseases, as well as the development of the world’s first rare disease centre for children
  • Expand your knowledge on patient collaboration and patient centric models with the stream on patient engagement, covering improvement strategies, patient-led trials, and much more
  • Gather further insight on drug approval and reimbursement with MAA, and how techniques for drug repurposing in the rare disease area can help treatment.

For more information visit the website at www.orphandrugs.co.uk/bentham or contact the team on email: kwilliams@smi-online.co.uk or call +44 (0) 207 827 6012

Journal: Current Medicinal Chemistry

EBook: Frontiers in Anti-Cancer Drug Discovery Volume 6